Popsi Cube provides its pharmaceutical company sponsors with expertise in both clinical trial management and in IT services. This dual competency allows us to monitor phase I to IV clinical trials and develop tools which are specific to the needs ofour clients.
In addition to providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry, Popsi Cube is offering specific tailor made solutions and numerous applications in such fields as randomization, data capture, data management, or eCTMS compliant with EMEA and FDA regulations and quality guidelines to facilitate the clinical development process. In particular, we have developed an array of data capture solutions, from Digital Pen and Paper data capture, to eCRF, IVRS/IWRS and PDA/tablet PCs, allowing us to offer the technology that best matches the specificities of the study protocol.
To be able to best support the growing demands of our North American sponsors, Popsi Cube has decided to open a new affiliate in the US. The new company, Popsi Cube, Inc., is based in Philadelphia, PA. Our new location will allow us to support our growth objectives by establishing close relationships with our customers and by providing them with local, experienced management support for their projects.
The Company’s North American expansion is funded by a grant from COFACE on behalf of the French state, providing further recognition of the interest of our solutions and potential in North America.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.